PortfoliosLab logoPortfoliosLab logo
MCHS vs. KURE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

MCHS vs. KURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Matthews China Discovery Active ETF (MCHS) and KraneShares MSCI All China Health Care Index ETF (KURE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

MCHS vs. KURE - Yearly Performance Comparison


2026 (YTD)20252024
MCHS
Matthews China Discovery Active ETF
11.52%31.19%6.53%
KURE
KraneShares MSCI All China Health Care Index ETF
5.81%24.87%-13.43%

Returns By Period

In the year-to-date period, MCHS achieves a 11.52% return, which is significantly higher than KURE's 5.81% return.


MCHS

1D
-1.62%
1M
-6.16%
YTD
11.52%
6M
6.74%
1Y
32.30%
3Y*
5Y*
10Y*

KURE

1D
1.15%
1M
9.21%
YTD
5.81%
6M
-12.59%
1Y
17.33%
3Y*
-2.50%
5Y*
-11.08%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


MCHS vs. KURE - Expense Ratio Comparison

MCHS has a 0.89% expense ratio, which is higher than KURE's 0.65% expense ratio.


Return for Risk

MCHS vs. KURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MCHS
MCHS Risk / Return Rank: 6666
Overall Rank
MCHS Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
MCHS Sortino Ratio Rank: 6868
Sortino Ratio Rank
MCHS Omega Ratio Rank: 6868
Omega Ratio Rank
MCHS Calmar Ratio Rank: 6666
Calmar Ratio Rank
MCHS Martin Ratio Rank: 6262
Martin Ratio Rank

KURE
KURE Risk / Return Rank: 2727
Overall Rank
KURE Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
KURE Sortino Ratio Rank: 3030
Sortino Ratio Rank
KURE Omega Ratio Rank: 2828
Omega Ratio Rank
KURE Calmar Ratio Rank: 2525
Calmar Ratio Rank
KURE Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MCHS vs. KURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Matthews China Discovery Active ETF (MCHS) and KraneShares MSCI All China Health Care Index ETF (KURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MCHSKUREDifference

Sharpe ratio

Return per unit of total volatility

1.26

0.60

+0.66

Sortino ratio

Return per unit of downside risk

1.81

0.97

+0.85

Omega ratio

Gain probability vs. loss probability

1.27

1.13

+0.14

Calmar ratio

Return relative to maximum drawdown

2.07

0.76

+1.31

Martin ratio

Return relative to average drawdown

7.49

1.59

+5.89

MCHS vs. KURE - Sharpe Ratio Comparison

The current MCHS Sharpe Ratio is 1.26, which is higher than the KURE Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of MCHS and KURE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


MCHSKUREDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.26

0.60

+0.66

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.35

Sharpe Ratio (All Time)

Calculated using the full available price history

0.80

-0.04

+0.84

Correlation

The correlation between MCHS and KURE is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

MCHS vs. KURE - Dividend Comparison

MCHS's dividend yield for the trailing twelve months is around 3.20%, less than KURE's 3.96% yield.


TTM20252024202320222021202020192018
MCHS
Matthews China Discovery Active ETF
3.20%3.56%5.48%0.00%0.00%0.00%0.00%0.00%0.00%
KURE
KraneShares MSCI All China Health Care Index ETF
3.96%4.19%1.29%0.65%0.05%14.12%0.00%0.25%0.21%

Drawdowns

MCHS vs. KURE - Drawdown Comparison

The maximum MCHS drawdown since its inception was -23.75%, smaller than the maximum KURE drawdown of -68.53%. Use the drawdown chart below to compare losses from any high point for MCHS and KURE.


Loading graphics...

Drawdown Indicators


MCHSKUREDifference

Max Drawdown

Largest peak-to-trough decline

-23.75%

-68.53%

+44.78%

Max Drawdown (1Y)

Largest decline over 1 year

-13.95%

-22.72%

+8.77%

Max Drawdown (5Y)

Largest decline over 5 years

-67.94%

Current Drawdown

Current decline from peak

-10.92%

-53.93%

+43.01%

Average Drawdown

Average peak-to-trough decline

-7.98%

-37.69%

+29.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.40%

10.78%

-6.38%

Volatility

MCHS vs. KURE - Volatility Comparison

The current volatility for Matthews China Discovery Active ETF (MCHS) is 7.22%, while KraneShares MSCI All China Health Care Index ETF (KURE) has a volatility of 8.60%. This indicates that MCHS experiences smaller price fluctuations and is considered to be less risky than KURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


MCHSKUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.22%

8.60%

-1.38%

Volatility (6M)

Calculated over the trailing 6-month period

15.40%

18.23%

-2.83%

Volatility (1Y)

Calculated over the trailing 1-year period

25.79%

29.09%

-3.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.87%

31.94%

-4.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.87%

32.54%

-4.67%